Compile Data Set for Download or QSAR
maximum 50k data
Found 7 Enz. Inhib. hit(s) with all data for entry = 1194
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312193(3-(p-methyl-benzyl)- syndonimine-N- phenylcarbamoy...)
Affinity DataKi:  190nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312223(3-(p-fluorobenzyl)- syndonimine-N- phenylcarbamoyl...)
Affinity DataKi:  460nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312192(3-(p-carboxylbenzyl)- syndonimine N- phenylcarbamo...)
Affinity DataKi:  2.70E+3nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312200(3-(phenylpropyl)- syndonimine-N- phenylcarbamoyl |...)
Affinity DataKi:  2.50E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312189(3-(benzyl)- syndonimine-N- phenylcarbamoyl | US960...)
Affinity DataKi:  3.60E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312195(3-phenethyl- syndonimine-N- (3',4'-dichlorophenyl)...)
Affinity DataKi:  4.00E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Caliper Life Sciences

US Patent
LigandPNGBDBM312196(3-(p-nitrophenethyl) syndonimine-N- (3',4'-dinitro...)
Affinity DataKi:  1.00E+5nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent